Literature DB >> 14962283

Reduction of anti-Galalpha1,3Gal antibodies by infusion of types 2 and 6 gal trisaccharides conjugated to poly-L-lysine.

K Kuwaki1, C Knosalla, K Moran, A Alt, A G Katopodis, R O Duthaler, H-J Schuurman, M Awwad, D K C Cooper.   

Abstract

To investigate the specificity of anti-Galalpha1,3Gal (Gal) antibodies (Abs) with respect to Gal oligosaccharides of types 2 and 6, eight baboons received an intravenous infusion of either a poly-l-lysine conjugate of Gal type 2 (n = 5) or type 6 (n = 3), followed 48 h later by the alternative Gal type 6 or 2 conjugate, respectively. IgM Abs reactive to Gal type 2 were depleted by 80 to 89% by either Gal conjugate. IgM reactive to Gal type 6 was less efficiently depleted by the Gal type 2 conjugate (57% depletion) than the Gal type 6 (82% depletion). Gal-reactive IgG was depleted more slowly and less efficiently by either glycoconjugate (initially by only 28 to 54%). Our results indicate that the Gal type 6 conjugate depletes most anti-Gal IgM, but the Gal type 2 conjugate is less efficient in depleting anti-Gal IgM reactive with type 6. There remain small fractions of antibody that are unadsorbed, particularly of IgG, probably due to their low affinity and distribution in both the intra- and extra-vascular compartments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962283     DOI: 10.1046/j.1399-3089.2003.00096.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  3 in total

1.  Barriers to the successful treatment of liver disease by hepatocyte transplantation.

Authors:  Kyle A Soltys; Alejandro Soto-Gutiérrez; Masaki Nagaya; Kevin M Baskin; Melvin Deutsch; Ryotaro Ito; Benjamin L Shneider; Robert Squires; Jerry Vockley; Chandan Guha; Jayanta Roy-Chowdhury; Stephen C Strom; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2010-06-30       Impact factor: 25.083

Review 2.  Modifying the sugar icing on the transplantation cake.

Authors:  David K C Cooper
Journal:  Glycobiology       Date:  2016-03-01       Impact factor: 4.313

3.  Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens.

Authors:  Mary Kearns-Jonker; Natasha Barteneva; Robert Mencel; Namath Hussain; Irina Shulkin; Alan Xu; Margaret Yew; Donald V Cramer
Journal:  BMC Immunol       Date:  2007-03-12       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.